Sumary of Morrison is a leader with his back against the wall and he's lashing out at the wrong place:
- On Wednesday Morrison told a news conference he (or the government) made a “constant appeal” to the Australian Technical Advisory Group on Immunisation (ATAGI) to review its advice on AstraZeneca according to the balance of risk.
- On July 13 it said where there was an outbreak and the Pfizer supply was constrained, people under 60 without immediate access to Pfizer should “reassess the benefits to them and their contacts from being vaccinated with COVID-19 vaccine AstraZeneca, versus the rare risk of a serious side effect”.
- WatchDuration: 2 minutes 15 seconds2m 15s The Prime Minister says ‘sorry’ for problems with vaccine rollout.
- A paper by the Kirby Institute’s Raina MacIntyre and other authors published in this month’s issue of the international journal Vaccine reported their “risk-benefit analysis for Australians aged 18–59”, comparing the risk of AZ vaccination with the risk of COVID infection.
- Read moreThe authors concluded: “In Australia, the potential risks of the AZD1222 vaccine in younger adults, who are at low risk of dying from COVID-19, may outweigh the benefits.
- “The article also said: “The latest policy decision to avoid use of this vaccine in adults <
- 60 years in Australia is entirely consistent with past vaccine risk–benefit policy decisions when rare but serious adverse events were identified.
- That was the same day ATAGI advised against AZ for under 50s, with the government announcing this at a hastily called night news conference.